Class information for:
Level 1: TOLL LIKE RECEPTORS//TOLL LIKE RECEPTOR 9//TLR4

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
13681 820 48.2 92%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
449 3       FAMILIAL MEDITERRANEAN FEVER//TOLL LIKE RECEPTORS//INFLAMMASOME 25887
543 2             TOLL LIKE RECEPTORS//INNATE IMMUNITY//CPG ODN 14712
13681 1                   TOLL LIKE RECEPTORS//TOLL LIKE RECEPTOR 9//TLR4 820

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 TOLL LIKE RECEPTORS authKW 211580 21% 3% 173
2 TOLL LIKE RECEPTOR 9 authKW 148895 4% 13% 30
3 TLR4 authKW 129722 8% 5% 68
4 TOLL LIKE RECEPTOR 4 authKW 101440 7% 5% 60
5 TOLL LIKE RECEPTOR 3 authKW 85077 2% 11% 20
6 95D CELL authKW 74474 0% 100% 2
7 DSRNA THERAPY authKW 74474 0% 100% 2
8 TLR9 authKW 59700 3% 7% 24
9 LIVER SMMU address 49648 0% 67% 2
10 ORAL SQAUMOUS CELL CARCINOMA authKW 49648 0% 67% 2

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Oncology 6990 48% 0% 392
2 Immunology 1601 22% 0% 183
3 Cell Biology 391 13% 0% 106
4 Gastroenterology & Hepatology 346 7% 0% 57
5 Medicine, Research & Experimental 340 9% 0% 71
6 Pathology 132 4% 0% 35
7 Biochemistry & Molecular Biology 62 12% 0% 98
8 Genetics & Heredity 43 5% 0% 37
9 Dentistry, Oral Surgery & Medicine 25 2% 0% 16
10 Hematology 22 2% 0% 20

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 LIVER SMMU 49648 0% 67% 2
2 ACUPUNCTURE 5 37237 0% 100% 1
3 AFFILIATE JIANGSU PEOPLES HOSP 37237 0% 100% 1
4 AFFILIATED CHANG ZHENG HOSP 37237 0% 100% 1
5 AFFILLIATED ZHONGDA HOSP 37237 0% 100% 1
6 ANAL DIS 37237 0% 100% 1
7 ANAT HISTOL FORENS ORTHOPAED SCI DAHFMO 37237 0% 100% 1
8 ANHUI PROV PATHOGEN BIOL ZOONOSES 37237 0% 100% 1
9 BREAST VASC SURG 37237 0% 100% 1
10 CANC CANC CONTROL LIAONING PROV 37237 0% 100% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 ONCOIMMUNOLOGY 5591 1% 1% 12
2 TUMOR BIOLOGY 2903 3% 0% 22
3 CANCER IMMUNOLOGY IMMUNOTHERAPY 2751 2% 0% 18
4 INNATE IMMUNITY 1812 1% 1% 5
5 CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY 1549 1% 1% 5
6 FRONTIERS IN IMMUNOLOGY 1266 1% 0% 10
7 BMC CANCER 985 2% 0% 14
8 ONCOTARGETS AND THERAPY 943 1% 0% 7
9 CANCER BIOLOGY & THERAPY 836 1% 0% 8
10 CANCER RESEARCH 759 4% 0% 29

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 TOLL LIKE RECEPTORS 211580 21% 3% 173 Search TOLL+LIKE+RECEPTORS Search TOLL+LIKE+RECEPTORS
2 TOLL LIKE RECEPTOR 9 148895 4% 13% 30 Search TOLL+LIKE+RECEPTOR+9 Search TOLL+LIKE+RECEPTOR+9
3 TLR4 129722 8% 5% 68 Search TLR4 Search TLR4
4 TOLL LIKE RECEPTOR 4 101440 7% 5% 60 Search TOLL+LIKE+RECEPTOR+4 Search TOLL+LIKE+RECEPTOR+4
5 TOLL LIKE RECEPTOR 3 85077 2% 11% 20 Search TOLL+LIKE+RECEPTOR+3 Search TOLL+LIKE+RECEPTOR+3
6 95D CELL 74474 0% 100% 2 Search 95D+CELL Search 95D+CELL
7 DSRNA THERAPY 74474 0% 100% 2 Search DSRNA+THERAPY Search DSRNA+THERAPY
8 TLR9 59700 3% 7% 24 Search TLR9 Search TLR9
9 ORAL SQAUMOUS CELL CARCINOMA 49648 0% 67% 2 Search ORAL+SQAUMOUS+CELL+CARCINOMA Search ORAL+SQAUMOUS+CELL+CARCINOMA
10 MYD88 43211 3% 5% 25 Search MYD88 Search MYD88

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 DAJON, M , IRIBARREN, K , CREMER, I , (2017) TOLL-LIKE RECEPTOR STIMULATION IN CANCER: A PRO- AND ANTI-TUMOR DOUBLE-EDGED SWORD.IMMUNOBIOLOGY. VOL. 222. ISSUE 1. P. 89 -100 73 56% 3
2 YU, L , WANG, LT , CHEN, SW , (2013) DUAL CHARACTER OF TOLL-LIKE RECEPTOR SIGNALING: PRO-TUMORIGENIC EFFECTS AND ANTI-TUMOR FUNCTIONS.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1835. ISSUE 2. P. 144 -154 71 59% 18
3 BASITH, S , MANAVALAN, B , YOO, TH , KIM, SG , CHOI, S , (2012) ROLES OF TOLL-LIKE RECEPTORS IN CANCER: A DOUBLE-EDGED SWORD FOR DEFENSE AND OFFENSE.ARCHIVES OF PHARMACAL RESEARCH. VOL. 35. ISSUE 8. P. 1297-1316 71 50% 58
4 YU, L , WANG, LT , CHEN, SW , (2012) EXOGENOUS OR ENDOGENOUS TOLL-LIKE RECEPTOR LIGANDS: WHICH IS THE MVP IN TUMORIGENESIS?.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 69. ISSUE 6. P. 935 -949 71 53% 13
5 MAI, CW , KANG, YB , PICHIKA, MR , (2013) SHOULD A TOLL-LIKE RECEPTOR 4 (TLR-4) AGONIST OR ANTAGONIST BE DESIGNED TO TREAT CANCER? TLR-4: ITS EXPRESSION AND EFFECTS IN THE TEN MOST COMMON CANCERS.ONCOTARGETS AND THERAPY. VOL. 6. ISSUE . P. 1573-1587 73 46% 26
6 ZOU, H , WANG, WK , LIU, YL , BRADDOCK, M , ZHENG, MH , HUANGG, DS , (2016) TOLL-LIKE RECEPTORS IN HEPATOCELLULAR CARCINOMA: POTENTIAL NOVEL TARGETS FOR PHARMACOLOGICAL INTERVENTION.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 20. ISSUE 9. P. 1127 -1135 50 56% 0
7 ZHU, LB , YUAN, H , JIANG, T , WANG, RX , MA, HX , ZHANG, SY , (2013) ASSOCIATION OF TLR2 AND TLR4 POLYMORPHISMS WITH RISK OF CANCER: A META-ANALYSIS.PLOS ONE. VOL. 8. ISSUE 12. P. - 39 64% 9
8 SEMLALI, A , JALOULI, M , PARINE, NR , AL AMRI, A , ARAFAH, M , AL NAEEM, A , AJAJ, SA , ROUABHIA, M , ALANAZI, MS , (2017) TOLL-LIKE RECEPTOR 4 AS A PREDICTOR OF CLINICAL OUTCOMES OF ESTROGEN RECEPTOR-NEGATIVE BREAST CANCER IN SAUDI WOMEN.ONCOTARGETS AND THERAPY. VOL. 10. ISSUE . P. 1207 -1216 34 65% 0
9 GOMAZ, A , PAVELIC, J , GLAVAN, TM , (2012) THE POLYMORPHISMS IN TOLL-LIKE RECEPTOR GENES AND CANCER RISK.PERIODICUM BIOLOGORUM. VOL. 114. ISSUE 4. P. 461-469 35 69% 0
10 KHAN, AA , KHAN, Z , WARNAKULASURIYA, S , (2016) CANCER-ASSOCIATED TOLL-LIKE RECEPTOR MODULATION AND INSINUATION IN INFECTION SUSCEPTIBILITY: ASSOCIATION OR COINCIDENCE?.ANNALS OF ONCOLOGY. VOL. 27. ISSUE 6. P. 984 -997 54 36% 1

Classes with closest relation at Level 1



Rank Class id link
1 14603 TOLL LIKE RECEPTORS//TLR6//TOLL LIKE RECEPTOR 4
2 4753 TOLL LIKE RECEPTORS//TLR7//TOLL LIKE RECEPTOR 7
3 36064 DERMO EPIDERMAL SEPARATION//INNATE IMMUNITY OF THE SKIN//PERMAFROST MICROORGANISMS
4 23898 POLY ICLC//RAUSCHER MURINE LEUKEMIA VIRUS//BANZI VIRUS
5 13288 IRAK 4//TIR DOMAIN//IRAK
6 4649 CPG ODN//CPG MOTIF//CPG DNA
7 21562 FLAGELLIN//TLR5//TOLL LIKE RECEPTOR 5
8 21325 MUCHMORE S INFECT DIS//COLIBACTIN//USC 1360
9 12109 TOLL LIKE RECEPTORS//TOLL LIKE RECEPTOR 4//TOLL LIKE RECEPTOR 2
10 19949 TOLL LIKE RECEPTORS//BETA AMYLOID PEPTIDES 25 35//IMMUNOPATHOL INFECT DIS GROUPING IRG GRI

Go to start page